Additionally, RES enhances SIRT3 expression, increases intracellular TGF-b deacetylation, hinders intracellular TGF-b signaling and fibrotic responses, and mitigates the activated phenotype of fibroblasts in SSc (171). The gene discussed is TGFB1; the disease is systemic sclerosis.